Free research / Peptide starting point
Retatrutide research
Browse source-linked original-study metadata associated with Retatrutide. Records are selected by a bounded search and automated metadata rules; they are not reviewed Pependium judgments about safety or effectiveness. Check each original source for its full methods and current status.
Sustained weight loss exceeding 100 kg with sequential incretin-based therapy in Prader-Willi syndrome.
Retatrutide-Associated Improvements in Cardiovascular Risk Biomarkers in Adults With Obesity With or Without Type 2 Diabetes.
Comparative effects of semaglutide tirzepatide and retatrutide on renal fibrosis in UUO and aged mice.
Effects of retatrutide on learning and memory in streptozotocin-induced male diabetic rats.
Efficacy and safety of retatrutide, a GIP, GLP-1, and glucagon receptor agonist, in people with type 2 diabetes and inadequate glycaemic control with diet and exercise (TRANSCEND-T2D-1): a double-blind, randomised, phase 3 trial.
GIPR:GCGR co-agonism restores normal weight in obese rodents.
Multi-omic profiling reveals Retatrutide alleviates adipose tissue fibrosis via metabolic reprogramming and tissue repair.
Check collection progress and source responses · All peptide pages